{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:59:23Z","timestamp":1790189963206,"version":"4.1.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"37","license":[{"start":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T00:00:00Z","timestamp":1757635200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9,12]]},"abstract":"<jats:p>Parkinson disease (PD) is the world\u2019s second most common neurodegenerative disorder. Currently, no medications can reverse its progression, and treatment primarily relies on single-target drugs that fail to comprehensively regulate the complex disease network. Zhengan Xifeng decoction (ZGXFD) contains multiple active components capable of targeting PD through multiple pathways. Clinical studies have demonstrated that ZGXFD combined with Madopar significantly improves symptoms in PD patients. Therefore, the aim of this study was to investigate the active ingredients, key targets, and potential molecular mechanisms of ZGXFD in the treatment of PD using network pharmacology combined with molecular docking. The active ingredients and corresponding targets of ZGXFD and related targets of PD were collected from the public databases. Then analyzing active ingredients, targets, and possible signal pathway of ZGXFD in treating PD by network pharmacology. The binding ability of the active ingredients to the target proteins was predicted by molecular docking. The study revealed 139 active ingredients and 119 PD-related targets of ZGXFD, among which the top 3 active ingredients were \u03b2-sitosterol, palmitic acid, and calcium carbonate. Brain-derived neurotrophic factor is a key target for ZGXFD in treating PD. The neuroactive ligand\u2013receptor interaction signaling pathway may play an important role in treating PD by ZGXFD. Molecular docking results showed the top 5 active ingredients all exhibited favorable binding affinities with the target proteins, among which \u03b2-sitosterol demonstrated the lowest average binding energy with the 5 key targets. In summary, this study screened the active ingredients of ZGXFD and preliminarily predicted its potential targets and pathways for anti-Parkinsonian effects. These findings await further experimental validation, thus providing a substantial theoretical foundation for subsequent research into the anti-Parkinsonian mechanisms of ZGXFD and the development of related products.<\/jats:p>","DOI":"10.1097\/md.0000000000044587","type":"journal-article","created":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T21:00:37Z","timestamp":1757970037000},"page":"e44587","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Exploring the mechanism of Zhengan Xifeng decoction in treating Parkinson disease based on network pharmacology and molecular docking"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-8016-7675","authenticated-orcid":false,"given":"Yidan","family":"Xu","sequence":"first","affiliation":[{"name":"Department of Pharmacy, The People\u2019s Hospital of Leshan, Leshan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangjun","family":"Yu","sequence":"additional","affiliation":[{"name":"West China School of Pharmacy, Sichuan University, Chengdu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260923","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ncl.2024.12.003","article-title":"Pathogenesis of Parkinson\u2019s disease.","volume":"43","author":"Xiao","year":"2025","journal-title":"Neurol Clin"},{"key":"R2-20260923","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1056\/NEJMra2401857","article-title":"Parkinson\u2019s disease.","volume":"391","author":"Tanner","year":"2024","journal-title":"N Engl J Med"},{"key":"R3-20260923","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40035-019-0162-z","article-title":"Parkinson\u2019s disease in China: a forty-year growing track of bedside work.","volume":"8","author":"Li","year":"2019","journal-title":"Transl Neurodegeneration"},{"key":"R4-20260923","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/s41582-024-01034-x","article-title":"Parkinson disease therapy: current strategies and future research priorities.","volume":"20","author":"Stocchi","year":"2024","journal-title":"Nat Rev Neurol"},{"key":"R5-20260923","doi-asserted-by":"crossref","first-page":"6416","DOI":"10.3390\/ijms26136416","article-title":"Parkinson disease signaling pathways, molecular mechanisms, and potential therapeutic strategies: a comprehensive review.","volume":"26","author":"Khan","year":"2025","journal-title":"Int J Mol Sci"},{"key":"R6-20260923","doi-asserted-by":"crossref","first-page":"e14292","DOI":"10.1097\/MD.0000000000014292","article-title":"Herbal medicine (Zhengan Xifeng decoction) for essential hypertension protocol for a systematic review and meta-analysis.","volume":"98","author":"Huang","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"R7-20260923","first-page":"1232","article-title":"The research overview of Zhengan Xifeng decoction in the treatment of Parkinson\u2019s disease.","volume":"35","author":"Dong","year":"2023","journal-title":"Clin J Tradit Chi Med"},{"key":"R8-20260923","first-page":"1993","article-title":"Effects of Zhengan Xifeng decoction on oxidative stress in the striatum of a rat model of Parkinson\u2019s disease.","volume":"16","author":"Wu","year":"2018","journal-title":"Chin J Integr Med Cardio Cerebrovasc Dis"},{"key":"R9-20260923","first-page":"2117","article-title":"Influence of Zhengan Xifeng decoction on \u03b1-synuclein expression in a mouse model of Parkinson\u2019s disease.","volume":"42","author":"Guo","year":"2021","journal-title":"J Qiqihar Med Univ"},{"key":"R10-20260923","first-page":"2301","article-title":"Zhengan Xifeng decoction ameliorates MPTP-induced Parkinson\u2019s disease in mice via the Nrf2\/HO-1 pathway.","volume":"43","author":"Qin","year":"2022","journal-title":"J Qiqihar Med Univ"},{"key":"R11-20260923","first-page":"194","article-title":"Clinical observation on the therapeutic effect of Zhengan Xifeng decoction combined with dopamine tablets in the treatmentof Parkinson\u2019s disease.","volume":"27","author":"Wu","year":"2020","journal-title":"Capital Food Med"},{"key":"R12-20260923","first-page":"1642","article-title":"Effects of Madopar combined with Zhengan Xifeng decoction on serum neurotransmitter expression in patients with Parkinson\u2019s disease.","volume":"23","author":"Liu","year":"2022","journal-title":"J Chronic Dis"},{"key":"R13-20260923","first-page":"64","article-title":"Analysis of the improvement effect of Zhengan Xifeng decoction plus reduction combined with Medopa on autonomic nerves ofelderly Parkinson\u2019s disease patients.","volume":"12","author":"Li","year":"2020","journal-title":"Chin Med Clin Res"},{"key":"R14-20260923","first-page":"1","article-title":"BATMAN-TCM: a bioinformatics analysis tool for molecular mechanism of traditional chinese medicine.","volume":"6","author":"Liu","year":"2016","journal-title":"Sci Rep"},{"key":"R15-20260923","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1758-2946-6-13","article-title":"TCMSP: a database of systems pharmacology for drug discovery from herbal medicines.","volume":"6","author":"Ru","year":"2014","journal-title":"J Cheminf"},{"key":"R16-20260923","doi-asserted-by":"crossref","first-page":"940166","DOI":"10.3389\/fnagi.2022.940166","article-title":"Molecular mechanism of Epimedium in the treatment of vascular dementia based on network pharmacology and molecular docking.","volume":"14","author":"Xie","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"R17-20260923","doi-asserted-by":"crossref","first-page":"112866","DOI":"10.1016\/j.biopha.2022.112866","article-title":"The potential applications of traditional Chinese medicine in Parkinson\u2019s disease: a new opportunity.","volume":"149","author":"Chen","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"R18-20260923","doi-asserted-by":"crossref","first-page":"114821","DOI":"10.1016\/j.jep.2021.114821","article-title":"Antioxidative role of traditional chinese medicine in Parkinson\u2019s disease.","volume":"285","author":"Muhammad","year":"2022","journal-title":"J Ethnopharmacol"},{"key":"R19-20260923","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1038\/nbt1007-1110","article-title":"Network pharmacology.","volume":"25","author":"Hopkins","year":"2007","journal-title":"Nat Biotechnol"},{"key":"R20-20260923","doi-asserted-by":"crossref","first-page":"110117","DOI":"10.1016\/j.cbi.2022.110117","article-title":"Multifunctional roles and pharmacological potential of \u03b2-sitosterol: emerging evidence toward clinical applications.","volume":"365","author":"Khan","year":"2022","journal-title":"Chem Biol Interact"},{"key":"R21-20260923","doi-asserted-by":"crossref","first-page":"123","DOI":"10.21010\/ajtcam.v14i1.13","article-title":"Evaluation of the anti-inflammatory capacity of beta-sitosterol in rodent assays.","volume":"14","author":"Paniagua-P\u00e9rez","year":"2016","journal-title":"AJTCAM"},{"key":"R22-20260923","doi-asserted-by":"crossref","first-page":"111","DOI":"10.26438\/ijsrbs\/v6i2.111118","article-title":"Isolation and characterisation of beta-sitosterol from the rhizomes of arisaema utile and its evaluation for antioxidant activity.","volume":"6","author":"Bhat","year":"2019","journal-title":"Int J Sci Res Biol Sci"},{"key":"R23-20260923","doi-asserted-by":"crossref","first-page":"12255","DOI":"10.3390\/ijms222212255","article-title":"Phytosterols: potential metabolic modulators in neurodegenerative diseases.","volume":"22","author":"Sharma","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R24-20260923","first-page":"1011","article-title":"Correlation between blood palmitic acid, \u03c9-6, \u03c9-3 and LDL-C in patients with acute ischemic stroke.","volume":"25","author":"Li","year":"2021","journal-title":"Chin J Laboratory Diagnosis"},{"key":"R26-20260923","first-page":"69","article-title":"Observation on the efficacy of ZhenganXifeng decoction combined with Dopamine tablets in the treatmentof Parkinson\u2019s disease and its effect on serum BDNF, IGF-1 and NT-3.","volume":"14","author":"Lu","year":"2019","journal-title":"World J Integr Tradit Western Med"},{"key":"R27-20260923","doi-asserted-by":"crossref","first-page":"7777","DOI":"10.3390\/ijms21207777","article-title":"Neurotrophic factor BDNF, physiological functions and therapeutic potential in depression, neurodegeneration and brain cancer.","volume":"21","author":"Colucci-D\u2019Amato","year":"2020","journal-title":"Int J Mol Sci"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000044587","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:01:05Z","timestamp":1790186465000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000044587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,12]]},"references-count":26,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000044587","relation":{},"ISSN":["1536-5964","0025-7974"],"issn-type":[{"value":"1536-5964","type":"electronic"},{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,12]]},"assertion":[{"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-25","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}